Actinomycosis pathophysiology

Actinomycosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Actinomycosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Actinomycosis pathophysiology On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Actinomycosis pathophysiology All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Actinomycosis pathophysiology
CDC on Actinomycosis pathophysiology
Actinomycosis pathophysiology in the news
Blogs on Actinomycosis pathophysiology
to Hospitals Treating Actinomycosis
Risk calculators and risk factors for Actinomycosis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Pathophysiology

• 6 species cause disease in humans:

  • A. israelii
  • A. Naeslundii
  • A. odontolyticus
  • A. viscosus
  • A. Meyeri
  • A. gerencseriae

• Gram positive filamentous rod
• Sulfur Granules
• Actinomyces from within, Nocardia from without
• Generally low pathogenicity and cause disease only in the setting of antecedent tissue injury

References

Template:Bacterial diseases
Template:SIB de:Aktinomykose gl:Actinomicose hr:Aktinomikoza nl:Actinomycose sr:Актиномикоза fi:Aktinomykoosi uk:Актиномікоз